Pulmonary Function Testing Devices Market size to surpass $6.5 Billion by 2035 | Top players include MGC Diagnostics Corporation, CareFusion Corporation (BD), Nihon Kohden Corporation, Medisoft (EuroMed), Cosmed

Market Outlook and Forecast

The pulmonary function testing devices market continues to demonstrate steady expansion, driven by rising respiratory disease prevalence, aging populations, and increasing emphasis on early diagnosis. In 2025, the global pulmonary function testing devices market was valued at USD 3.5 billion, reflecting strong demand across developed healthcare systems and expanding adoption in emerging economies. By 2035, the market is projected to reach USD 6.5 billion, supported by a growth forecast of 7.2% CAGR during 2026-2035.

This sustained growth highlights the increasing role of pulmonary diagnostics in both acute and chronic care settings. Pulmonary function testing devices are now widely integrated into routine health assessments, preoperative evaluations, and long-term disease management programs.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8042

Regional Performance Highlights

Asia Pacific is expected to account for approximately 38% share by 2035, making it the largest regional market. Rapid urbanization, rising air pollution levels, increasing smoking prevalence in certain countries, and expanding healthcare infrastructure are key contributors. Countries such as China, India, and Japan are witnessing growing demand for spirometry and advanced lung function testing as respiratory disease awareness improves.

North America is projected to hold a 36% share by 2035, driven by high diagnostic penetration, strong reimbursement frameworks, and advanced healthcare infrastructure. The region benefits from widespread use of pulmonary testing in hospitals, outpatient clinics, and specialized respiratory care centers, along with continuous innovation by leading medical device manufacturers.

Europe remains a mature yet innovation-driven market, supported by structured screening programs, strong clinical guidelines, and growing adoption of digital pulmonary diagnostics. The region places significant emphasis on preventive care and chronic disease management, sustaining demand for reliable and accurate pulmonary function testing devices.

➤ Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Pulmonary Function Testing Devices Report Overview here: https://www.researchnester.com/reports/pulmonary-function-testing-devices-market/8042

Segment Demand

By end user, hospitals and clinics dominate the pulmonary function testing devices market, accounting for an estimated 67% share by 2035. These settings require comprehensive pulmonary testing solutions to support diagnostics, treatment planning, and ongoing monitoring for both inpatient and outpatient populations.

Hospitals and clinics utilize a broad range of devices, including spirometers, plethysmographs, and gas exchange analyzers, to manage complex respiratory cases. The increasing integration of pulmonary testing into routine clinical workflows has further strengthened demand from this segment.

➤ Discover how the Pulmonary Function Testing Devices Market is evolving globally - access your free sample report → https://www.researchnester.com/sample-request-8042

Top Market Trends

1. Shift Toward Portable and Point-of-Care Testing

One of the most prominent trends in the pulmonary function testing devices market is the growing demand for portable and point-of-care solutions. Compact, handheld spirometers and mobile testing devices are gaining traction in outpatient clinics, primary care settings, and home-based care environments.

These devices enable faster diagnosis, improve patient convenience, and support decentralized healthcare delivery. Recent product introductions have focused on improving accuracy while maintaining portability, making pulmonary testing more accessible beyond traditional hospital environments.

2. Digitalization and Connected Pulmonary Diagnostics

Digital connectivity is reshaping how pulmonary function testing data is collected, stored, and analyzed. Modern devices increasingly feature cloud-based data management, electronic health record (EHR) integration, and remote monitoring capabilities.

This trend allows clinicians to track patient lung function over time, support telemedicine consultations, and enhance clinical decision-making. Connected pulmonary testing devices are particularly valuable for managing chronic respiratory conditions, where longitudinal data is critical for treatment optimization.

3. Growing Focus on Preventive and Early Diagnosis

Preventive healthcare has become a major driver of demand for pulmonary function testing devices. Healthcare providers are increasingly using spirometry and related tests for early detection of respiratory impairment, even before symptoms become severe.

This trend is supported by public health initiatives aimed at reducing the long-term burden of chronic respiratory diseases. Early diagnosis enables timely intervention, improving patient outcomes and reducing healthcare costs over the long term.

➤ Stay ahead of the curve with the latest Pulmonary Function Testing Devices Market trends. Claim your sample report → https://www.researchnester.com/sample-request-8042

Recent Company Developments

The pulmonary function testing devices market features a mix of established medical device manufacturers and specialized diagnostic companies. Competitive strategies are centered on product innovation, digital integration, and geographic expansion.

Medtronic continues to strengthen its respiratory diagnostics portfolio by integrating pulmonary testing capabilities with broader respiratory care solutions, supporting comprehensive disease management.

Koninklijke Philips has focused on digital respiratory diagnostics, incorporating pulmonary function testing into connected care platforms that support remote monitoring and data-driven clinical insights.

Vyaire Medical remains a key player in pulmonary diagnostics, with recent product enhancements aimed at improving testing accuracy and workflow efficiency in hospital and clinic environments.

CareFusion (BD) has continued to support the pulmonary function testing market through advanced spirometry solutions tailored for clinical and research applications.

COSMED has expanded its pulmonary diagnostics offerings with portable and laboratory-grade devices, addressing demand across sports medicine, clinical research, and healthcare settings.

➤ Request Free Sample PDF Report @https://www.researchnester.com/sample-request-8042

➤ Related news:
https://www.linkedin.com/pulse/postoperative-pain-therapeutics-market-evolving-strategies-rida-patel-ninaf/
https://www.linkedin.com/pulse/brain-machine-interface-market-size-analyzing-trends-projected-patel-pqqbf/

Contact Data
AJ Daniel
Corporate Sales, USA
Research Nester
77 Water Street 8th Floor, New York, 10005
Email: info@researchnester.com
USA Phone: +1 646 586 9123
Europe Phone: +44 203 608 5919

About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.